Literature DB >> 17002573

Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice.

Chung Fang Lai1, Su-Li Cheng, Gabriel Mbalaviele, Christine Donsante, Marcus Watkins, Glenn L Radice, Roberto Civitelli.   

Abstract

UNLABELLED: Ovariectomy-induced bone loss is accentuated in mice with germline Cdh2 haploinsufficiency, the result of a decreased osteoblastogenesis in the face of normal osteoclast number. Reduced N-cadherin abundance in these mice decreases cell-cell adhesion and alters signaling pathways important for osteoblast commitment and differentiation, thus providing in vivo evidence that N-cadherin-mediated cell-cell interactions are involved in homeostatic responses to increased bone remodeling.
INTRODUCTION: We have shown that targeted expression of a dominant negative truncated form of N-cadherin (Cdh2) delays acquisition of peak bone mass in mice and retards osteoblast differentiation. We tested the role of this molecule in the skeletal homeostatic response to ovariectomy in mice with germline Cdh2 haploinsufficiency.
MATERIALS AND METHODS: Heterozygous Cdh2 null (Cdh2+/-) and wildtype mice were ovariectomized and followed up to 13 weeks by in vivo radiodensitometric and ex vivo histologic assessment of bone mass and turnover. Cells isolated from wildtype and Cdh2+/- mice were used to determine the alterations in bone cell function produced by partial loss of N-cadherin.
RESULTS: Bone mass was not significantly different between Cdh2+/- and wildtype littermates, but on ovariectomy, bone loss in Cdh2+/- mice was initially slower, but with time it became significantly greater than in wildtype mice. This accentuated bone loss was associated with lower osteoblast number and serum osteocalcin levels, with no differences in bone resorption. Although development of calcified nodules was faster in calvaria cells isolated from Cdh2+/- mice relative to Cdh2+/+ cells, bone marrow osteogenic precursors were lower in the former than in the latter genotypes. Cdh2 expression was downregulated with differentiation in wildtype calvaria cells, whereas cadherin-11 abundance remained unchanged. Furthermore, cell-cell adhesion (postconfluence) was decreased among heterozygous calvaria cells, as was cell proliferation (preconfluence), relative to wildtype cells. Finally, the abundance and cellular distribution of beta-catenin was minimally decreased in Cdh2+/- cells, whereas mitogen-activated protein kinase (MAPK) signaling was more active in Cdh2 insufficient cells.
CONCLUSIONS: Cdh2 is involved in the homeostatic bone formation response to ovariectomy, presumably by regulating osteoprogenitors number and differentiation through stabilization of cell-cell adhesion and/or signaling modulation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17002573     DOI: 10.1359/jbmr.060906

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  21 in total

1.  Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells.

Authors:  Olga Bromberg; Benjamin J Frisch; Jonathan M Weber; Rebecca L Porter; Roberto Civitelli; Laura M Calvi
Journal:  Blood       Date:  2012-05-17       Impact factor: 22.113

Review 2.  Cadherin-mediated cell-cell adhesion and signaling in the skeleton.

Authors:  Pierre J Marie; Eric Haÿ; Dominique Modrowski; Leila Revollo; Gabriel Mbalaviele; Roberto Civitelli
Journal:  Calcif Tissue Int       Date:  2013-05-09       Impact factor: 4.333

3.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

4.  N-cadherin Regulation of Bone Growth and Homeostasis Is Osteolineage Stage-Specific.

Authors:  Francesca Fontana; Cynthia L Hickman-Brecks; Valerie S Salazar; Leila Revollo; Grazia Abou-Ezzi; Susan K Grimston; Sung Yeop Jeong; Marcus Watkins; Manuela Fortunato; Yael Alippe; Daniel C Link; Gabriel Mbalaviele; Roberto Civitelli
Journal:  J Bone Miner Res       Date:  2017-03-29       Impact factor: 6.741

5.  The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.

Authors:  Xinming Su; Desiree H Floyd; Alun Hughes; Jingyu Xiang; Jochen G Schneider; Ozge Uluckan; Emanuela Heller; Hongju Deng; Wei Zou; Clarissa S Craft; Kaiming Wu; Angela C Hirbe; Dorota Grabowska; Mark C Eagleton; Sarah Townsley; Lynne Collins; David Piwnica-Worms; Thomas H Steinberg; Deborah V Novack; Pamela B Conley; Michelle A Hurchla; Michael Rogers; Katherine N Weilbaecher
Journal:  J Clin Invest       Date:  2012-09-17       Impact factor: 14.808

6.  N-cadherin adherens junctions mediate osteogenesis through PI3K signaling.

Authors:  Anyonya R Guntur; Clifford J Rosen; Michael C Naski
Journal:  Bone       Date:  2011-09-16       Impact factor: 4.398

7.  Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women.

Authors:  Ulrike I Mödder; Matthew M Roforth; Kelley Hoey; Louise K McCready; James M Peterson; David G Monroe; Merry Jo Oursler; Sundeep Khosla
Journal:  Bone       Date:  2011-04-29       Impact factor: 4.398

8.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

Review 9.  N-cadherin-mediated adhesion and signaling from development to disease: lessons from mice.

Authors:  Glenn L Radice
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

10.  N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action.

Authors:  Leila Revollo; Jacqueline Kading; Sung Yeop Jeong; Jiemin Li; Valerie Salazar; Gabriel Mbalaviele; Roberto Civitelli
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.